Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice.
暂无分享,去创建一个
[1] E. Rubin,et al. Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. , 1994, The Journal of clinical investigation.
[2] E. Rubin,et al. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice , 1993, Nature.
[3] R. Hammer,et al. Atherogenesis in transgenic mice expressing human apolipoprotein(a) , 1992, Nature.
[4] R. Hammer,et al. Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a). , 1992, The Journal of biological chemistry.
[5] R. Krauss,et al. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI , 1991, Nature.
[6] R. Lawn,et al. Lipoprotein(a) and atherosclerosis. , 1991, Annals of internal medicine.
[7] R. Krauss,et al. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[8] E. Boerwinkle,et al. Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. , 1990, The New England journal of medicine.
[9] V. Fuster,et al. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. , 1990, The Journal of clinical investigation.
[10] G. Utermann,et al. The mysteries of lipoprotein(a). , 1989, Science.
[11] D. Gordon,et al. High-density lipoprotein--the clinical implications of recent studies. , 1989, The New England journal of medicine.
[12] M. Debakey,et al. Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation. , 1989, Arteriosclerosis.
[13] M. Dietel,et al. Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. , 1989, Arteriosclerosis.
[14] R. Williams,et al. Quantitative assessment of atherosclerotic lesions in mice. , 1987, Atherosclerosis.
[15] E. Chen,et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen , 1987, Nature.
[16] J. Oram,et al. Interaction of high density lipoprotein with its receptor on cultured fibroblasts and macrophages. Evidence for reversible binding at the cell surface without internalization. , 1987, The Journal of biological chemistry.
[17] J. Fruchart,et al. Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles. , 1987, Biochemical and biophysical research communications.
[18] V. Armstrong,et al. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels. , 1986, Atherosclerosis.
[19] A. Scanu,et al. Functional Roles of Plasma High Density Lipoprotein , 1982 .
[20] A. Scanu,et al. Functional roles of plasma high density lipoproteins. , 1982, CRC critical reviews in biochemistry.
[21] F. Grillo,et al. Improved method for determination of high-density-lipoprotein cholesterol I. Isolation of high-density lipoproteins by use of polyethylene glycol 6000. , 1981, Clinical chemistry.
[22] J. Glomset,et al. The plasma lecithins:cholesterol acyltransferase reaction. , 1968, Journal of lipid research.